[1] Miceli MH, Diaz JA, Lee SA.Emerging opportunistic yeast infections[J]. Lancet Infect Dis, 2011, 11(2):142-151. [2] Pfaller MA.Diekema DJ.Epidemiology of invasive candidiasis:a persistent public health problem[J].ClinMicrobiol Rev, 2007, 20(1):133-163. [3] 王惠平.白念珠菌对唑类抗真菌药物分子耐药机制的研究进展[J].中国麻风皮肤病杂志, 2010, 26(5): 342-344. [4] Cabral ME, Figueroa LI, Fariña JI.Synergistic antifungal activity of statin-azole associations as witnessed by Saccharomyces cerevisiae and Candida utilis-bioassays and ergosterol quantification[J]. Rev Iberoam Micol, 2013, 30(1):31-38. [5] Menezes EA, VasconcelosJúnior AA, Silva CL, et al.In vitro synergism of simvastatin and fluconazole against Candida species[J]. Rev Inst Med Trop Sao Paulo, 2012, 54(4):197-199. [6] 曹先伟, 冀朝辉, 李若瑜, 等.白色念珠菌对唑类抗真菌药物的耐药机制探讨[J].中华医院感染学杂志, 2007, 17(3):258-262. [7] Bink A, Kucharíková S, Neirinck B, et al.The nonsteroidal antiinflammatory drug diclofenac potentiates the in vivo activity of caspofungin against Candida albicans biofilms[J]. Infect Dis, 2012, 206(11):1790-1797. [8] Argenta JS, Alves SH, Silveira F, et al.In vitro and in vivo susceptibility of two-drug and three-drug combinations of terbinafine, itraconazole, caspofungin, ibuprofen and fluvastatin against Pythiuminsidiosum[J].Vet Microbiol, 2012, 157(1-2):137-142. [9] Kofla G, Turner V, Schulz B, et al.Doxorubicin induces drug efflux pumps in Candida albicans[J].Med Mycol, 2011, 49(2):132-142. [10] Zhai B, Wu C, Wang L, et al.The antidepressant sertraline provides a promising therapeutic option for neurotropic Cryptococcal infections[J]. Antimicrob Agents Chemother, 2012, 56(7):3758-3766. [11] Shinde RB, Chauhan NM, Raut JS, et al.Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A[J]. Ann ClinMicrobiolAntimicrob, 2012, 11:27. [12] Singh-Babak SD, Shekhar T, Smith AM, et al.A novel calcineurin-independent activity of cyclosporin A in Saccharomyces cerevisiae[J].Mol Biosyst, 2012, 8(10):2575-2584. |